<?xml version="1.0" encoding="UTF-8"?>
<ref id="B56">
 <label>56</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Malyuchenko</surname>
    <given-names>NV</given-names>
   </name>
   <name>
    <surname>Kotova</surname>
    <given-names>EY</given-names>
   </name>
   <name>
    <surname>Kulaeva</surname>
    <given-names>OI</given-names>
   </name>
   <name>
    <surname>Kirpichnikov</surname>
    <given-names>MP</given-names>
   </name>
   <name>
    <surname>Studitskiy</surname>
    <given-names>VM</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>PARP1 Inhibitors: antitumor drug design</article-title>. 
  <source>Acta Naturae</source> (
  <year>2015</year>) 
  <volume>7</volume>(
  <issue>3</issue>):
  <fpage>27</fpage>â€“
  <lpage>37</lpage>. 
  <pub-id pub-id-type="doi">10.32607/20758251-2015-7-3-27-37</pub-id>
  <pub-id pub-id-type="pmid">26483957</pub-id>
 </mixed-citation>
</ref>
